Retrospective Review of the Relationship Between Weight Change and Demographic Factors Following Initial Depot Medroxyprogesterone Acetate Injection in Adolescents

Clinical Therapeutics

Volumn 33, Issue 2, 2011, Pages 182-187

  Gerlach, Laura S ^a   Saldaña, Shannon N ^a,b   Wang, Yu ^a   Nick, Todd G ^c,d   Spigarelli, Michael G ^a,b  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^c ARKANSAS CHILDREN S HOSPITAL   (United States)

^d UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

Author keywords

Adolescent; Contraception; Depot medroxyprogesterone; Weight gain

Indexed keywords

MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ADULT; AGE; ARTICLE; CHILD; COHORT ANALYSIS; DEMOGRAPHY; FEMALE; HOSPITAL; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MENARCHE; NEGRO; SCHOOL CHILD; SIDE EFFECT; STATISTICAL ANALYSIS; WEIGHT CHANGE; WEIGHT GAIN;

ADOLESCENT; CHILD; CONTRACEPTIVE AGENTS; DELAYED-ACTION PREPARATIONS; HUMANS; INJECTIONS, INTRAMUSCULAR; LINEAR MODELS; MEDROXYPROGESTERONE ACETATE; MENARCHE; OBESITY; RETROSPECTIVE STUDIES; WEIGHT GAIN;

EID: 79954492114     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/j.clinthera.2011.02.008     Document Type: Article

References (14)

1. Depo-Provera® [package insert] 2006, Pfizer Inc, New York, NY.
2. Bonny A.E., Britto M.T., Huang B., et al. Weight gain, adiposity, and eating behaviors among adolescent females on depot medroxyprogesterone acetate (DMPA). J Pediatr Adolesc Gynecol 2004, 17:109-115.
3. Bonny A.E., Ziegler J., Harvey R., et al. Weight gain in obese and nonobese adolescent girls initiating depot medroxyprogesterone, oral contraceptive pills, or no hormonal contraceptive method. Arch Pediatr Adolesc Med 2006, 160:40-45.
4. Chotnopparatpattara P., Taneepanichskul S. Use of depot medroxyprogesterone acetate in Thai adolescents. Contraception 2000, 62:137-140.
5. Harel Z., Biro F.M., Kollar L.M., Rauh J.L. Adolescents' reasons for and experience after discontinuation of the long-acting contraceptives Depo-Provera and Norplant. J Adolesc Health 1996, 19:118-123.
6. Le Y.C., Rahman M., Berenson A.B. Early weight gain predicting later weight gain among depot medroxyprogesterone acetate users. Obstet Gynecol 2009, 114(2 Pt 1):279-284.
7. Lim S.W., Rieder J., Coupey S.M., Bijur P.E. Depot medroxyprogesterone acetate use in inner-city, minority adolescents: continuation rates and characteristics of long-term users. Arch Pediatr Adolesc Med Oct 1999, 153:1068-1072.
8. Mangan S.A., Larsen P.G., Hudson S. Overweight teens at increased risk for weight gain while using depot medroxyprogesterone acetate. J Pediatr Adolesc Gynecol 2002, 15:79-82.
9. O'Dell C.M., Forke C.M., Polaneczky M.M., et al. Depot medroxyprogesterone acetate or oral contraception in postpartum adolescents. Obstet Gynecol 1998, 91:609-614.
10. Polaneczky M., Liblanc M. Long-term depot medroxyprogesterone acetate (Depo-Provera) use in inner-city adolescents. J Adolesc Health 1998, 23:81-88.
11. Neovius M., Sundström J., Rasmussen F. Combined effects of overweight and smoking in late adolescence on subsequent mortality: nationwide cohort study. BMJ 2009, 338:b496.
12. Zlatnik F.J., Burmeister L.F. Low 'gynecologic': an obstetric risk factor. Am J Obstet Gynecol 1977, 128:183-186.
13. Bland M. An Introduction to Medical Statistics 2000, Oxford University Press, New York, NY. 3rd ed.
14. Streuling I., Beyerlein A., von Kries R. Can gestational weight gain be modified by increasing physical activity and diet counseling?. A meta-analysis of interventional trials. Am J Clin Nutr 2010, 92:678-687.